Page 18 - Term Sheet News Today

PRESS RELEASE – INSIDE INFORMATION Biosenic signs term sheet with SPRIM Global Investments (TrialCap fund) for up to USD 8 million debt financing and USD 800,000 equity investment as a first decisive, financing step towards a Phase 3 clinical trial for its ground-breaking auto-immune medication, a first-in-class drug oral arsenic salt. Mont-Saint-Guibert, Belgium, December 6, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing ...

“Exits through acquisition are critical to creating and maintaining a self-sustaining cycle of innovation,” a letter singed by the firms reads.

An interesting, but little-known compliance requirement makes private equity and VC firm employees register as lobbyists.

In 2018, Khosla Ventures wrote a $50 million check to OpenAI, though he says it was “almost impossible to diligence.”

The combined firm will have a collective investment value of over $9.7 billion.

The 301-page tome is filled with bizarre anecdotes about the culture at the world’s largest hedge fund.

RE:CONDENSED CONSOLIDATED INTERIM FINANCIALS STATEMENTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 The third quarter financial statements for the three and...

Shein has plenty of enemies in Washington, D.C.—and they may throw a wrench in the company’s plans to go public.

Fizzled projects, high turnover, and political red tape have put a damper on Elon Musk’s big tunnel plans.

A private equity lawsuit showcases the supposed bad acts of a fired exec.